Emerging Markets Solid For Novartis But Slower In 2015?
This article was originally published in PharmAsia News
Executive Summary
Novartis has reported generally strong growth in emerging markets in the calendar fourth quarter and 2014, but says a range of factors may to contribute to a likely slowdown this year.